BiotechTube

Alteplase

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Stroke

Conditions

Stroke

Trial Timeline

Dec 1, 2006 → Jun 1, 2008

NCT ID
NCT00412867

About Alteplase

Alteplase is a approved stage product being developed by Kyowa Kirin for Stroke. The current trial status is completed. This product is registered under clinical trial identifier NCT00412867. Target conditions include Stroke.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00412867ApprovedCompleted

Competing Products

20 competing products in Stroke

See all competitors
ProductCompanyStageHype Score
SPT-07A injectionSinopharmPhase 3
76
Osmotic drugsSinopharmPre-clinical
22
Aspirin, ClopidogrelYuhanPre-clinical
23
DS-1040b + PlaceboDaiichi SankyoPhase 1/2
41
SUN13837 + placeboDaiichi SankyoPhase 2
52
DS-1040b + AspirinDaiichi SankyoPhase 1
33
piclozotan low dose + placebo + piclozotan high doseDaiichi SankyoPhase 2
52
DS1040b + PlaceboDaiichi SankyoPre-clinical
23
Pharmacological intensification based on olmesartanDaiichi SankyoPhase 2
52
warfarin tablets + Edoxaban tablets (high dose regimen-60mg) + Edoxaban tablets (low dose regimen-30mg) + placebo warfarin + placebo edoxabanDaiichi SankyoPhase 3
77
YM872 (zonampanel), t-PA (alteplase)Astellas PharmaPhase 2
52
ASP2246Astellas PharmaPhase 1/2
41
Neu2000KWL + Neu2000KWL + Neu2000KWL + PlacebosSun PharmaceuticalPhase 2
52
XY03-EA + XY03-EA PlaceboSun PharmaceuticalPhase 2
52
Redasemtide + PlaceboShionogiPhase 2
52
StatinShionogiApproved
85
ONO-2506 + ONO-2506 + ONO-2506Ono PharmaceuticalPhase 2/3
65
AbciximabEli LillyPhase 3
77
AbciximabEli LillyPhase 3
77
SB623 Implant (2.5M) + SB623 Implant (5.0M)Sumitomo PharmaPhase 2
52

Other Products from Kyowa Kirin

KRN23Approved
85
Istradefylline PillApproved
85
MogamulizumabApproved
85
KRN23Approved
85
KHK4827-Active + KHK4827-PlaceboApproved
85